Home HPTN
Structure
Research
Sites
Community Ethics Prevention
Science
HPTN Studies Network
Information
Site Map

Community Participation

 

Community Working Group

 

Regional Working Groups

 

Community Educators

 

Site Activities & Research

 

Community Involvement Toolbox

 

CORE CIP

 

Key Topics & Resources

 

Lessons Learned

 

Community FAQs


Community Participation

A key factor of the overall HIV Prevention Trials Network (HPTN) strategy is the commitment to community participation at all levels of research. Directed by Federal guidelines, the HPTN has committed to community participation and collaboration as a key component in the Network's goal of effective public health research. As a result, a partnership of people who are affected and infected by the HIV epidemic will have input into the ideas that are developed, how the studies are designed, and the implementation of the actual research.

To ensure movement toward this goal, community participation must be facilitated to occur within the HPTN CORE, at the sites where research is to be implemented, and within the research communities. A system of information sharing and resources helps ensure information is exchanged between these levels of the Network. Information on these community web pages provide information and guidance for site staff and the community partners about community participation in the Network as well as how to develop and sustain it in the HIV prevention research conducted at the sites.

HPTN Commitment
The HPTN's commitment to community participation in research is based on the positive findings of research initiatives in the past that showed the research produces outcomes that are more likely to be integrated into communities and there is mutual benefit to the communities and the researchers when community is involved in the process.

Understanding what is expected in the community participation process is important. The Network proceeded with its community program based on guidelines given to us by the Division of AIDS (DAIDS), US National Institutes of Health (NIH), and was initiated during the HIVNET trials. The mandate for community participation in the Network was also outlined in the original request for the Network proposal in 1999; the NIH Request for Application (RFA) for the HPTN stated that applicants must "… ensure community input into the research process and to foster a partnership between researchers and the community, particularly the population served by the individual unit and/or research study."

Community participation in decision-making ensures that research participants and the community feel ownership of the research and have an interest in its success. Collaborations and partnerships encourage trust and mutual understanding of the research issues and implications. An additional benefit to the collaborative effort is that the prevention research developed will be based on respect for cultural and ethnic differences among participants. "Where there is community participation in research, human capacity is built, with the ultimate results being self-determination, self-reliance, and a high self-esteem." (Janet Frohlich, HPTN CWG co-Chair)

Community representatives should be involved in an early and sustained manner in the design, development, implementation and distribution of results of HIV vaccine research "…in order to ensure the ethical and scientific quality of the proposed research, its relevance to the affected community, and its acceptance by the affected community." (UNAIDS)

HPTN Guidance
The HPTN provides guidance and resources to Network participants to provide an outline for both community advisory board members and site staff on what could and should be taking place to encourage collaborative and participatory decision-making and educational activities. In order to do this, some expectations need to be understood.

  • At the community level, members of the community need to know they can safely share their experiences and ideas about what aspects of proposed research will and will not work in their communities.
  • At the site level, HPTUs must invest appropriate resources in planning for and implementation of activities that develop and sustain community participation at each stage and all levels of the HPTN trials process while responding to community questions and concerns in a timely fashion.
  •  At the Network level, there must be willingness to respond to identified needs and concerns regarding community involvement and decisions while facilitating the flow of this information to all levels.

Additional guidance from the HPTN CORE in the form of a document was provided for HPTN Year One activities to further clarify the HPTN's commitment to a strong community involvement program.

Community and Site-based Participation
Local community advisory processes in the HPTN incorporate some common elements and must work together to create a solid working relationship that invites community participation. Site staff work to support the process locally to ensure these elements are in place.

  • Clinical trials of HIV prevention interventions are most likely to succeed when all the parties concerned - researchers, government, manufacturers, and community - regard the trials as a collaborative process. Community members, particularly potential trial volunteers and people from the populations from which volunteers will be recruited, can and should play an integral role in advising on research trials.
  • Sustained relationships and communication with community members are the responsibility of the Principal Investigator at each site. Site Community Education staff help with the site's community commitment by facilitating the development of a written plan to actively engage community participation.
  • The site must identify ways to foster trust, to ensure respect of social, cultural, and political realities of the communities where recruitment will take place, and to maximize opportunities for dialogue about the implementation of research trials. This involvement and participation of community members will be supported as an integral part of the site operation plan.
  • Community members need to be involved in early discussions about prevention research priorities, particularly when the research is in the design phase of the protocol development process. Community input is important to a variety of issues including: research design such as cohort selection criteria, questionnaire design, and follow-up plans; informed consent procedures; risk-reduction interventions; community education and outreach; and recruitment and retention planning and implementation.
  • A community advisory mechanism has been established at each of the HPTN sites. The most common way to do this has been to create a Community Advisory Board (CAB). Each site's advisory structure may vary based on local needs and direction.

Network-based Participation
Creating a network that integrates community perspective requires participation in the leadership bodies of the HPTN. The strategy employed is two-fold: create a self-governing working group to assess and advocate for community issues in the Network, and for community representatives to be active partners in the decision-making committees within the Network.

The HPTN CORE established a Community Working Group (CWG) that meets on a regular basis. Members from each research site will participate in conference calls and be ensured representation at an annual retreat. The CWG meets to identify cross-cutting issues for the site communities, advocate for resolution of community issues within the Network, identify training needs, and facilitate information exchange. Community representatives from the three Regional Working Groups (RWGs) are on the CWG where they exchange information and discuss issues from the sites.

The HPTN CORE is responsible for outlining steps to develop, maintain, support, and encourage the full participation of community representatives in all phases of the research process. This includes plans for community education, training, recruitment, ongoing orientation, and facilitate access to participation on science direction working groups and network governance committees.

Science Working Groups (SWGs)
Science Working Groups (SWGs) are where concepts for HIV prevention research in the Network are developed. Two community representatives are on each of the science working groups, one representative from a United States site and the other from an international site. By having community representatives in each of the SWGs, community perspectives are represented at the start of a research topic before it becomes a protocol. Find more about the SWGs, including who is representing the community on each of the groups, by going to the SWG page.

Protocol Teams
Protocol teams are where individual research concepts are developed into protocols. The team has representation from each site that is interested in the research concept in order to address site-specific research issues while the protocol is developed and implemented. The CORE has advised that each site involved in the protocol needs to include a community representative to facilitate information exchange with the protocol team and the site's community advisory members. A guidance document was issued in 2000 called "Community Participation in Protocol Teams" that outlines the Network expectations of including community perspectives on protocol teams.

Ethics Working Group
Many of the issues associated with community involvement in HIV prevention research are based in ethical questions. Two community representatives from the CWG, one U.S. and one international, participate in the Ethics Working Group to build a stronger connection between community efforts at the sites, as well as CWG and Network efforts concerning ethics.

Network Committees
To ensure a scientifically relevant research agenda that meets accepted ethical considerations and community standards the Network has established oversight committees. Community representatives (one International and one U.S.) have been included in the following committees:

  • Protocol Review Committee (PRC) - reviews protocols before they go to the NIH for approval and offers suggestions and comments to the team to help with the final review.
  • Network Evaluation Committee (NEC) - responsible for the development and annual review of Network measures to assess how well the Network is functioning and meeting goals and objectives.
  • Executive Committee (EC) - responsible for leading and governing the Network including setting research agenda, managing the budget, and addressing issues of concern. The two community representatives on the EC are members from the Community Working Group.
      
 

Send any questions or comments regarding this site to: hptn@fhi.org
Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: June 07, 2007